Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of the Lymphatic System01:15

Development of the Lymphatic System

2.8K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lymphovascular Invasion in SOUND-Eligible Breast Cancer: Implications for Occult Axillary Nodal Metastasis.

Annals of surgical oncology·2026
Same author

Interpersonal Experiences and Mental Health Among Low-Income Black and Latino Adults.

Journal of transcultural nursing : official journal of the Transcultural Nursing Society·2026
Same author

Integration of Artificial Intelligence in Qualitative Research.

Journal of transcultural nursing : official journal of the Transcultural Nursing Society·2026
Same author

Cardiac-Gated Diffusion-Weighted Magnetic Resonance Imaging Assessment of Kidney Function in Patients With Kidney Cancer.

Kidney international reports·2026
Same author

Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial.

European urology·2026
Same author

Pharmacotherapy agents in prevention and treatment of breast cancer-related lymphedema: a systematic scoping review.

Frontiers in oncology·2026

Related Experiment Video

Updated: Apr 30, 2026

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.0K

Proactive approach to lymphedema risk reduction: a prospective study.

Mei R Fu1, Deborah Axelrod, Amber A Guth

  • 1College of Nursing, New York University, New York, NY, USA, mf67@nyu.edu.

Annals of Surgical Oncology
|May 10, 2014
PubMed
Summary

The Optimal Lymph Flow program effectively reduces lymphedema risk in breast cancer survivors. This patient-centered approach promotes lymph flow and optimizes BMI, shifting care towards proactive risk reduction.

More Related Videos

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
05:44

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

Published on: January 12, 2017

9.9K
A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
09:50

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

Published on: November 2, 2019

7.6K

Related Experiment Videos

Last Updated: Apr 30, 2026

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.0K
Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
05:44

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

Published on: January 12, 2017

9.9K
A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
09:50

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

Published on: November 2, 2019

7.6K

Area of Science:

  • Oncology
  • Lymphedema Management
  • Rehabilitation

Background:

  • Lymphedema remains a significant long-term challenge for breast cancer survivors despite advances in cancer treatment.
  • The Optimal Lymph Flow program offers a patient-centered educational and behavioral intervention.
  • Focuses on self-care strategies to enhance lymphedema risk reduction and optimize body mass index (BMI).

Purpose of the Study:

  • To preliminarily evaluate the effectiveness of The Optimal Lymph Flow program.
  • To assess its impact on lymphedema risk reduction and BMI optimization.
  • To explore its role in promoting lymph flow through patient self-care.

Main Methods:

  • Prospective, longitudinal, quasi-experimental design with repeated measures.
  • Recruited 140 patients, with 134 completing the 12-month follow-up (4% attrition).
  • Measured lymph volume (LV) via infrared perometer and BMI via bioimpedance device at baseline and follow-up points.

Main Results:

  • 97% of patients maintained or improved preoperative limb volume and BMI at 12 months.
  • Only 4 patients (2 with SLNB, 2 with axillary lymph node dissection) developed measurable lymphedema (>10% LV change).
  • Two of the four patients with lymphedema saw their LV return to baseline without compression by adhering to the program's exercises.

Conclusions:

  • The Optimal Lymph Flow program demonstrates effectiveness in enhancing lymphedema risk reduction.
  • Provides initial evidence for a paradigm shift in lymphedema care from treatment to proactive risk management.
  • Highlights the importance of patient education and self-care in managing postoperative challenges.